S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

Canadian EHR Interoperability Weak, Uneven, Harming Patients

Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information remains siloed across different software programs.

Angiolipoleiomyoma Masquerading as Leiomyoma in a Woman

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Adding Lanes to the Healthcare Highway

Patients can now call, message, upload photos, complete e-visits, see primary care, go to urgent care, or request specialty care directly. And yet the backlog keeps growing. So does the inbox.

Beyond CAR-T: The Rising Potential of Natural Killer Cells

Prof David Kerr explores gene-edited NK cells and allogeneic banks as a potent, ‘off-the-shelf’ alternative to autologous CAR-T infusions.

‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival

Dr F. Perry Wilson breaks down study findings suggesting a link between GLP-1 drugs and improved outcomes among patients with breast cancer and obesity.

Upper GI Disorders: New Evidence May Refine Practice

Dr David Johnson summarizes pivotal DDW 2026 studies, spotlighting emerging evidence across upper GI disorders — from Barrett’s esophagus surveillance to pancreatitis management.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information remains siloed across different software programs.

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Patients can now call, message, upload photos, complete e-visits, see primary care, go to urgent care, or request specialty care directly. And yet the backlog keeps growing. So does the inbox.

Prof David Kerr explores gene-edited NK cells and allogeneic banks as a potent, ‘off-the-shelf’ alternative to autologous CAR-T infusions.

Dr F. Perry Wilson breaks down study findings suggesting a link between GLP-1 drugs and improved outcomes among patients with breast cancer and obesity.

Dr David Johnson summarizes pivotal DDW 2026 studies, spotlighting emerging evidence across upper GI disorders — from Barrett’s esophagus surveillance to pancreatitis management.

News All Time

S4 Episode 3: How Much Monitoring Is Enough in Psoriasis Care?

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

The Half-Life of Medical Certainty

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

Infographic: How Much a Doctor’s Average Pay in the US Rose

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Man With Spinal Compression From Hepatocellular Carcinoma

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

From Pixels to Prescriptions: AI in Oncology Pathology

Digital pathology AI is moving from detection to treatment decisions. In part 2 of this series, here’s what’s FDA-cleared — and how it changes care in oncology practice.

Woman With Lateral Neck Cyst From Fourth Branchial Cleft

An uncommon congenital fourth branchial cleft cyst presents after exercise as a painless, mobile posterior neck mass, highlighting the need for prompt imaging and surgery.

A Man With Severe Gallbladder Dyskinesia

Severe gallbladder dysfunction may present without stones: a case of EF 2% on HIDA in a patient with fatty-meal pain whose pathology showed mild chronic cholecystitis.

Early PsA Detection: Biomarkers and Genetics

Dr Vinod Chandran discusses biomarkers, genetics, and clinical features that assess risk for psoriatic arthritis.

Precision Nutrition for Better Clinical Outcomes

Precision nutrition integrates genetics, the gut microbiome, metabolomics and lifestyle data to tailor dietary therapy promising better clinical outcomes.

When to Operate on a Pancreatic Cyst

More incidental pancreatic cysts are being found with modern imaging; physicians must weigh MRI surveillance against high risk surgery based on size, growth, and duct dilation.

S3 Episode 2: Endometrial Cancer Research: The Past, Present, and Future

Drs Ursula A. Matulonis and David G. Mutch discuss past and present endometrial cancer research, including the Route 66 SPORE.

S3 Episode 1: Phase 3 Trial ADCs in Endometrial Cancer

Drs Ursula Matulonis and Brian Slomovitz discuss phase 3 trials of ADCs in endometrial cancer and what's to come in the field of endometrial cancer therapeutics.

Lithium Beyond Bipolar: A New Role in Brain Health

Could lithium be more than a mood stabilizer? Dr James Greenblatt examines its emerging role in brain resilience and cognitive health.

The Thyroid Cancer Dilemma: Doing More Isn’t Always Better

With rising thyroid cancer rates but stable mortality, clinicians must weigh the costs of overdiagnosis to ensure precision care over unnecessary intervention.

S1 Episode 2: Can Early Genetic Testing Change ATTR-CM Outcomes?

Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.

Recommended News For You

examining differences in the rates of breast reconstruction following mastectomies.

Chronic pain and poor sleep are troublesome bed partners.

New guidelines for radiation therapy for HPV-associated head and neck cancer

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

The way that miR-377 inhibits cells that cause prostate cancer.

How 7,000 steps a day could help reduce your risk of cancer

Recommended Articles For You

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia 

Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

4.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

5.

According to research, the mineralization of the bone matrix controls the growth of tumor cells.

1.

Angina Haemorrhagica Bullosa: What You Need to Know

2.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

3.

Exploring the Role of Fecal Leukocytes in Intestinal Health

4.

Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies

5.

HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part X

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

4.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot